Clinical trials
Phase 1 Lymphoma, Non-Hodgkin trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 8 |
| 2020 | 12 |
| 2021 | 8 |
| 2022 | 12 |
| 2023 | 8 |
| 2024 | 7 |
| 2025 | 6 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 28 |
| Recruiting | 22 |
| Completed | 11 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Zhejiang University | 6 |
| Chongqing Precision Biotech Co., Ltd | 3 |
| He Huang | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Janssen Research & Development, LLC | 3 |
| Timmune Biotech Inc. | 3 |
| Axter Therapeutics (Beijing) Co., Ltd | 2 |
| Bayer | 2 |
| Chinese PLA General Hospital | 2 |
| Jecho Biopharmaceuticals Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 79 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Recurrence | 12 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 9 |
| Lymphoma, B-Cell | 7 |
| Multiple Myeloma | 7 |
| Lymphoma | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, T-Cell, Peripheral | 4 |
| Leukemia, Myeloid, Acute | 2 |
Trials
Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.